Mabscale, LLC

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: Private

Employees: -

Market Cap: -

Website: http://mabscale.ru/

Clinical Trials

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Phase 1

Active, not recruiting

Conditions: Rheumatoid Arthritis

Interventions: Drug: MabThera®
Drug: Rituximab

First Posted Date: 2023-12-18

Last Posted Date: 2024-06-06

Lead Sponsor: Mabscale, LLC

Target Recruit Count: 208

Registration Number: NCT06175338

Locations: 🇷🇺
LLC "Medical Center Revma-Med", Kemerovo, Russian Federation
🇷🇺
LLC "Korolev Family Clinic №4", Korolev, Russian Federation
🇷🇺
JSC "Northwestern Center for Evidence-Based Medicine", Saint-Petersburg, Russian Federation

and more 9 locations

Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®

Phase 3

Recruiting

Conditions: Plaque Psoriasis

Interventions: Drug: Humira
Drug: Adalimumab

First Posted Date: 2023-08-22

Last Posted Date: 2023-11-29

Lead Sponsor: Mabscale, LLC

Target Recruit Count: 494

Registration Number: NCT06005532

Locations: 🇷🇺
Regional dermatovenerologic dispensary, Barnaul, Russian Federation
🇷🇺
City clinical hospital n.a.Botkin, Moscow, Russian Federation
🇷🇺
Reafan, Novosibirsk, Russian Federation

and more 6 locations

Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man

Phase 1

Active, not recruiting

Conditions: Healthy Men

Interventions: Drug: Pertuzumab
Drug: Perjeta®

First Posted Date: 2023-04-24

Last Posted Date: 2024-08-16

Lead Sponsor: Mabscale, LLC

Target Recruit Count: 114

Registration Number: NCT05825781

Locations: 🇷🇺
Central Clinical Hospital "RZD-Medicina", Moscow, Russian Federation

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Phase 3

Recruiting

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Bevacizumab
Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2022-12-16

Last Posted Date: 2024-08-16

Lead Sponsor: Mabscale, LLC

Target Recruit Count: 620

Registration Number: NCT05654454

Locations: 🇷🇺
Smolensk oncologic dispensary, Smolensk, Russian Federation
🇷🇺
Leningrad regional clinical hospital, Saint Petersburg, Russian Federation
🇷🇺
Northwestern Center for Evidence-Based Medicine, Saint Petersburg, Russian Federation

and more 25 locations

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy